Bypassing Gastric Bypass Surgery
A number of companies are developing minimally invasive devices that produce the weight-reducing effects of a gastric bypass minus the actual surgery.
weight loss
Compulsive Eating Similar to Drug Addiction, Researchers Say
A new study from the Scripps Research Institute has shown that the molecular mechanism that causes drug addiction is the same mechanism that drives people to compulsively eat.
Implantable Weight-Loss Device Receives CE Mark Approval
GI Dynamics has received European CE mark approval to commercialize a non-surgical device for the management of obesity and Type 2 diabetes.
Three Companies Race for Obesity Drug Approval
The race for an anti-obesity drug intensified Wednesday with the latest mid-stage trial data from Orexigen Therapeutics.
NeuroSearch’s Tesofensine Advances to Phase III Testing
Yesterday, OneMedPlace reported on several companies that are developing anti-obesity drugs. Another name can be added to the list.
VIVUS’ Qnexa Shows Promise For Diabetics
VIVUS, a pharmaceutical company specializing in products to treat sexual function, announced that their experimental obesity drug Qnexa was shown to improve blood sugar control in patients with type 2 diabetes.